Robuta

https://www.fool.com/investing/2019/11/06/heres-why-gw-pharmaceuticals-is-falling-today.aspx
Epidiolex sales during the third quarter were pretty good but still less thrilling than investors have gotten used to.
gw pharmaceuticalsfallingtodaymotley
https://www.fool.com/investing/2018/06/14/why-marijuana-stock-gw-pharmaceuticals-gained-21-i.aspx
The biotech has an FDA decision pending on its epilepsy drug.
gw pharmaceuticalsmarijuanastockgainedmay